晶豐明源(688368.SH):重大資產重組事項恢復審核
格隆匯2月28日丨晶豐明源(688368.SH)公佈,此前披露,公司擬向南京凌鷗創芯電子有限公司(簡稱“凌鷗創芯”)李鵬等14名股東以發行股份及支付現金購買其持有的凌鷗創芯95.75%股權,同時公司擬向不超過35名特定對象發行股份募集配套資金(簡稱“本次重大資產重組”),募集配套資金總額不超過19,372.87萬元。
由於本次重大資產重組申請文件中記載的財務資料有效期至2021年12月31日止,為保持審核期間財務數據的有效性,公司向上海證券交易所申請中止審核本次重大資產重組。
目前,公司已完成對標的公司的加期審計和申請文件的更新工作,並協同廣發證券股份有限公司向上海證券交易所申請恢復本次交易申請文件的審核,已於2022年2月28日收到上海證券交易所同意恢復本次重大資產重組審核的通知。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.